Key Takeaways KBH beat Q2 EPS and revenue estimates, though both declined year over year. Lower net orders and affordability issues led KBH to reduce full-year revenue and margin guidance. Q2 home deliveries dropped 11% while backlog value fell 27% from the prior-year quarter.KB Home (KBH) stock surged 3% after it reported second-quarter fiscal 2025 results. The quarter’s earnings and total revenues surpassed the Zacks Consensus Estimate. However, both metrics decreased on a year-over-year basis.The quart ...

The Zacks Domestic Auto industry faces a tough road ahead as tariffs on imported vehicles and key auto parts are expected to disrupt supply chains and dampen consumer demand. New-vehicle sales slowed in May. Several auto biggies have withdrawn guidance amid tariff woes. At the same time, affordability issues and rising incentives are squeezing profit margins, while inflation and tariffs are complicating pricing strategies.The electric vehicle (EV) segment is growing, though at a more measured pace amid poli ...

Companies within the Zacks Cosmetics industry are facing a rapidly shifting macroeconomic environment, marked by rising external pressure that is dampening consumer demand and weighing on overall sector performance. Weak sales trends are being further affected by escalating production and operational costs, which continue to strain profitability and efficiency.Despite these headwinds, industry leaders such as The Estee Lauder Companies Inc. (EL) , Coty Inc. (COTY) and European Wax Center, Inc. (EWCZ) are le ...

Shares of VTEX (VTEX) have gained 5% over the past four weeks to close the last trading session at $6.50, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8.8 indicates a potential upside of 35.4%.The average comprises six short-term price targets ranging from a low of $7.30 to a high of $10.00, with a standard deviation of $1.33. While the lowest estimate indicates an increase ...

Red Robin (RRGB) closed the last trading session at $5.00, gaining 57.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $9.38 indicates an 87.6% upside potential.The average comprises four short-term price targets ranging from a low of $3.50 to a high of $12.00, with a standard deviation of $3.94. While the lowest estimate indicates a decline of 30% from the current price level, t ...

Euroseas Ltd. (ESEA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ESEA's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross."A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving averages being the ...

CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today its entry into the U.S. market and the launch of U.S.-based manufacturing through a strategic agreement with DolCas Biotech LLC (“DolCas”), a ...

Paris, 24 June 2025 Capitalised terms used herein shall have the meaning specified for such terms in the Caisse Française de Financement Local base prospectus to the €75,000,000,000 Euro Medium Term Note Programme dated 10 June 2025 (the “Base Prospectus”). Caisse Française de Financement Local has decided to issue on 26 June 2025 – Euro 10,000,000 Fixed Rate Obligations Foncières due 26 June 2048. The Base Prospectus dated 10 June 2025 approved by the Autorité des Marchés Financiers is available on the we ...

Biotech stock Nektar Therapeutics Inc (NASDAQ:NKTR) is soaring today, up 83.7% at $17.52 at last glance, after the company's eczema drug, rezpegaldesleukin, met its primary and secondary goals in a mid-stage study. NKTR is now headed for its best day since a 91.5% pop on August 7, 2023 (which occurred after promising data for the same drug). Breaking above several layers moving averages, including the 320-day trendline that kept a lid on mid-February gains, NKTR is now up 23.7% in 2025. Options traders are ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alongsid ...